ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Inhibrx Biosciences Inc

Inhibrx Biosciences Inc (INBX)

16.15
0.90
(5.90%)
Closed January 05 3:00PM
16.055
-0.095
(-0.59%)
After Hours: 6:59PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
16.15
Bid
13.00
Ask
17.54
Volume
68,882
14.89 Day's Range 16.41
10.80 52 Week Range 39.79
Market Cap
Previous Close
15.25
Open
15.31
Last Trade
1
@
16.15
Last Trade Time
Financial Volume
US$ 1,093,983
VWAP
15.882
Average Volume (3m)
68,972
Shares Outstanding
14,475,904
Dividend Yield
-
PE Ratio
-1.50
Earnings Per Share (EPS)
-10.71
Revenue
1.63M
Net Profit
-154.96M

About Inhibrx Biosciences Inc

We are a clinical-stage biotechnology company dedicated to helping people with life-threatening conditions through scientific innovation and excellence. We are a clinical-stage biotechnology company dedicated to helping people with life-threatening conditions through scientific innovation and excellence.

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Inhibrx Biosciences Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker INBX. The last closing price for Inhibrx Biosciences was US$15.25. Over the last year, Inhibrx Biosciences shares have traded in a share price range of US$ 10.80 to US$ 39.79.

Inhibrx Biosciences currently has 14,475,904 shares outstanding. The market capitalization of Inhibrx Biosciences is US$220.76 million. Inhibrx Biosciences has a price to earnings ratio (PE ratio) of -1.50.

INBX Latest News

Inhibrx Biosciences Reports Third Quarter 2024 Financial Results

Inhibrx Biosciences Reports Third Quarter 2024 Financial Results PR Newswire SAN DIEGO, Nov. 14, 2024 SAN DIEGO, Nov. 14, 2024 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx...

Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation

Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation PR Newswire SAN DIEGO, Nov. 4, 2024 SAN DIEGO, Nov. 4, 2024 /PRNewswire/ -- Inhibrx Biosciences, Inc...

Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights PR Newswire SAN DIEGO, Aug. 13, 2024 SAN DIEGO, Aug. 13, 2024 /PRNewswire/ -- Inhibrx...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.026.7415730337115.1316.05514.65895415.20716766CS
40.785.0748210800315.3716.05513.517233414.73978827CS
120.583.7251123956315.5717.4112.256897215.06762034CS
262.619.188191881913.5517.7910.89057214.60101208CS
52-22.22-57.909825384438.3739.7910.837224531.48759462CS
156-27.03-62.598425196943.1844.31687.6742500525.04879552CS
260-3.55-18.020304568519.750.977.6734101225.85839449CS

INBX - Frequently Asked Questions (FAQ)

What is the current Inhibrx Biosciences share price?
The current share price of Inhibrx Biosciences is US$ 16.15
How many Inhibrx Biosciences shares are in issue?
Inhibrx Biosciences has 14,475,904 shares in issue
What is the market cap of Inhibrx Biosciences?
The market capitalisation of Inhibrx Biosciences is USD 220.76M
What is the 1 year trading range for Inhibrx Biosciences share price?
Inhibrx Biosciences has traded in the range of US$ 10.80 to US$ 39.79 during the past year
What is the PE ratio of Inhibrx Biosciences?
The price to earnings ratio of Inhibrx Biosciences is -1.5
What is the cash to sales ratio of Inhibrx Biosciences?
The cash to sales ratio of Inhibrx Biosciences is 142.16
What is the reporting currency for Inhibrx Biosciences?
Inhibrx Biosciences reports financial results in USD
What is the latest annual turnover for Inhibrx Biosciences?
The latest annual turnover of Inhibrx Biosciences is USD 1.63M
What is the latest annual profit for Inhibrx Biosciences?
The latest annual profit of Inhibrx Biosciences is USD -154.96M
What is the registered address of Inhibrx Biosciences?
The registered address for Inhibrx Biosciences is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Inhibrx Biosciences website address?
The website address for Inhibrx Biosciences is www.inhibrx.com
Which industry sector does Inhibrx Biosciences operate in?
Inhibrx Biosciences operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
FCUVFocus Universal Inc
US$ 0.9499
(174.93%)
260.93M
NITON2OFF Inc
US$ 2.6306
(145.85%)
358.28M
CRNCCerence Inc
US$ 19.33
(143.76%)
161.8M
KITTNauticus Robotics Inc
US$ 3.8249
(140.56%)
104.8M
ACONAclarion Inc
US$ 0.2984
(110.14%)
305.64M
HWHHWH International Inc
US$ 0.4621
(-28.80%)
7.43M
SMSTDefiance Daily Target 2x Short MSTR ETF
US$ 5.69
(-26.30%)
24.77M
RAINRain Enhancement Technologies Holdco Inc
US$ 5.59
(-23.42%)
161.15k
PTLEPTL Ltd
US$ 9.35
(-23.30%)
1.04M
NXUNXU Inc
US$ 0.725868
(-22.78%)
7.59M
NITON2OFF Inc
US$ 2.6306
(145.85%)
350.92M
TGLTreasure Global Inc
US$ 0.382
(101.58%)
330.82M
ACONAclarion Inc
US$ 0.2984
(110.14%)
305.59M
FCUVFocus Universal Inc
US$ 0.9499
(174.93%)
259.78M
NVDANVIDIA Corporation
US$ 144.47
(4.45%)
222.72M

Your Recent History

Delayed Upgrade Clock